MoneyWorks4Me

Lactose India informs about disclosures

16 Jan 2026 Evaluate
Lactose India has informed that the Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(4)(f) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SST Private Family Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..